BUZZ-U.S. STOCKS ON THE MOVE-Joy Global, Second Sight, Encana
(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for the Day Ahead newsletter, link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/nex49s) U.S. stock index futures edged up on Thursday, after two days of declines on the S&P 500, ahead of data on the labor market and factory orders. Dow Jones industrial average e-mini futures were up 0.19 percent at 18,121, S&P 500 e-mini futures were up 0.19 percent at 2,100.5 and Nasdaq 100 e-mini futures were up 0.22 percent at 4,454.
** ABBVIE INC, Wednesday close $60.27, -4.68 pct premarket
** PHARMACYCLICS INC, Wednesday close $230.48, +10.68 pct premarket
AbbVie will buy Pharmacyclics for about $21 billion, giving it access to what is expected to be one of the world's top-selling cancer drugs and expanding its reach in the profitable oncology field. The deal, the latest example of a big drugmaker swooping on a biotech firm to refill its medicine pipeline, confounds expectations that Pharmacyclics would sell out to Johnson & Johnson.
** ARROWHEAD RESEARCH CORP, Wednesday close $7.51, +11.45 pct premarket
The drug developer said it acquired Novartis AG's RNAi assets, including various patents and three preclinical drugs.